It might be, who knows. If it is delayed, I think it would be due to something out of their control like the FDA. The FDA needs to respond to 2 ODD requests and an IND. You just never know with the FDA. If those things happen plus Lympro data etc then price will be much higher and uplist will happen.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links